Free Trial

iBio (IBIO) Insider Trading & Ownership

iBio logo
$2.48 +0.06 (+2.48%)
(As of 12/20/2024 ET)

iBio (NYSEMKT:IBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.58%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$64,609.40
Get IBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling iBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IBIO Insider Buying and Selling by Quarter

iBio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2023Martin BrennerInsiderSell210$6.20$1,302.00  
8/28/2023Martin BrennerInsiderSell250$6.20$1,550.00  
7/27/2023Martin BrennerInsiderSell225$10.20$2,295.00  
7/12/2023Martin BrennerInsiderSell2,351$11.80$27,741.80  
6/21/2023Martin BrennerInsiderSell209$13.60$2,842.40  
5/22/2023Martin BrennerInsiderSell209$18.80$3,929.20  
4/24/2023Martin BrennerInsiderSell219$24.00$5,256.00  
3/23/2023Martin BrennerInsiderSell260$42.60$11,076.00  
3/10/2022Robert Matthew LutzInsiderSell1,231$7.00$8,617.00  
(Data available from 1/1/2013 forward)

IBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at iBio includes Martin Brenner, and Robert Matthew Lutz. Learn more on insiders at IBIO.

0.58% of iBio stock is owned by insiders. Learn more on IBIO's insider holdings.

The following insider sold IBIO shares in the last 24 months: Martin Brenner ($55,992.40).

Insiders have sold a total of 3,933 iBio shares in the last 24 months for a total of $55,992.40 sold.

iBio Key Executives

  • Dr. Martin B. Brenner D.V.M. (Age 54)
    Ph.D., CEO, Chief Scientific Officer & Director
    Compensation: $753k
  • Mr. Felipe Duran (Age 45)
    Chief Financial Officer
    Compensation: $513.22k
  • Mr. Marc Banjak J.D.
    Chief Legal Officer
  • Ms. Kristi Sarno
    Senior VP of Business Development


This page (NYSEMKT:IBIO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners